EUVIMEDEUVIMED entdecken
Fallbericht

The first autopsy case of Epstein–Barr virus‐positive marginal zone lymphoma that deteriorated after COVID‐19 vaccination

Ziyao Wang, Reiji Muto, Hiroaki Miyoshi, Mikiko Aoki, Noriko Uesugi, Hiroyuki Murayama, Kosuke Masutani, Makoto Hamasaki

Pathology International · 2024

DOI: 10.1111/pin.13398 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology International, 2024. Verfasst von Ziyao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, COVID-19, Lymphoma, B-Cell, Marginal Zone, Lymphoproliferative Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is the first autopsy case of Epstein–Barr virus‐positive marginal zone lymphoma (EBV + MZL) with an other iatrogenic immunodeficiency‐associated lymphoproliferative disorders (LPD) (methotrexate [MTX]‐associated LPD) that deteriorated after the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine. This case had a unique immunophenotype. A 71‐year‐old female patient with rheumatoid arthritis receiving MTX presented with fatigue 1 week after the SARS‐CoV‐2 vaccination. She was hospitalized due to hepatorenal dysfunction and pancytopenia. Computed tomography revealed systemic lymphadenopathy. Her physical condition deteriorated, and the patient died. The autopsy revealed systemic lymphadenopathy comprising medium‐sized atypical lymphocytes and scattered Hodgkin/Reed–Sternberg (H/RS)‐like cells. An immunohistochemical examination showed that atypical lymphocytes were positive for CD79a and MUM‐1 and some were positive for CD20 and IRTA‐1. H/RS‐like cells were immunoreactive for CD30 and CD15 and ringed by T cells. Both cell types were positive for EBV‐encoded small RNA. The majority of H/RS‐like cells were positive for CD20, whereas a small number of CD3‐positive cells were admixed. We herein presented the first autopsy case of EBV + MZL that deteriorated after the SARS‐CoV‐2 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsCOVID-19Lymphoma, B-Cell, Marginal ZoneLymphoproliferative DisordersLymphadenopathyHumansFemaleAgedHerpesvirus 4, HumanCOVID-19 VaccinesSARS-CoV-2MethotrexateAutopsyVaccination

Stichwörter der Autor:innen

COVID-19SARS-CoV-2autopsymethotrexate-associated lymphoproliferative disorderother iatrogenic immunodeficiency-associated lymphoproliferative disordersvaccination

Substanzen

COVID-19 VaccinesMethotrexate

Autor:innen und Institutionen

  • Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
  • Department of Pathology, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Pathology, National Hospital Organization (NHO) Kumamoto Medical Center, Kumamoto, Japan.
  • Department of Internal Medicine, Division of Nephrology and Rheumatology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Zitieren

APA

Wang, Z., Muto, R., Miyoshi, H., Aoki, M., Uesugi, N., Murayama, H., Masutani, K., & Hamasaki, M. (2024). The first autopsy case of Epstein–Barr virus‐positive marginal zone lymphoma that deteriorated after COVID‐19 vaccination. Pathology International. https://doi.org/10.1111/pin.13398

Vancouver

Wang Z, Muto R, Miyoshi H, Aoki M, Uesugi N, Murayama H, et al. The first autopsy case of Epstein–Barr virus‐positive marginal zone lymphoma that deteriorated after COVID‐19 vaccination. Pathology International. 2024. doi:10.1111/pin.13398

BibTeX
@article{Wang2024,
  author = {Wang, Ziyao and Muto, Reiji and Miyoshi, Hiroaki and Aoki, Mikiko and Uesugi, Noriko and Murayama, Hiroyuki and Masutani, Kosuke and Hamasaki, Makoto},
  title = {The first autopsy case of Epstein–Barr virus‐positive marginal zone lymphoma that deteriorated after COVID‐19 vaccination},
  journal = {Pathology International},
  year = {2024},
  doi = {10.1111/pin.13398}
}
Kostenlos starten →